No Actual Numbers ? One would value a stock on how much market the company can capture and I have yet to see anyone on this board offer this valuation, this is what moves US pharma`s up big time. Debt also means dilution and where is the money coming from to produce the goods. It also scares me when individuals boast about how many shares they have as they will be the classic dumpers. With all that being said any I have to say with lots of experience on pharma stocks EKG could go anywhere but honestly Friday is never a true test of these measures because thats the way it always is and it is possible that the US buyers will push it higher into next week when they stumble across this on the weekend. GLTA